[Federal Register Volume 87, Number 120 (Thursday, June 23, 2022)]
[Notices]
[Pages 37520-37521]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-13419]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Novel and
Exceptional Technology and Research Advisory Committee.
The meeting will be held as a virtual meeting and is open to the
public. Individuals who plan to view the virtual meeting and need
special assistance or other reasonable accommodations to view the
meeting should notify the Contact Person listed below in advance of the
meeting. The meeting will be videocast and can be accessed from the NIH
Videocasting and Podcasting website (http://videocast.nih.gov/).
Name of Committee: Novel and Exceptional Technology and Research
Advisory Committee.
Date: July 14, 2022.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: The Novel and Exceptional Technology and Research
Advisory Committee meeting will include an update from the Working
Group on Data Science and Emerging Technology and discussion of next
steps regarding the current charge to the committee, delivered in
June 2021.
Place: National Institutes of Health, 6705 Rockledge Drive,
Suite 630, Bethesda, MD 20892 (Virtual Meeting Link will be
available at https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings).
Contact Person: Jessica Tucker, Office of Science Policy,
National Institutes of Health, 6705 Rockledge Drive, Suite 630,
Bethesda, MD 20892, 301-496-9838, [email protected].
Any interested person may file written comments by forwarding
the statement to the Contact Person listed on this notice at least
two business days prior to the meeting date. The statement should
include the name, address, telephone number and, when applicable,
the business or professional affiliation of the interested person.
Other than name and contact information, please do not include any
personally identifiable information or any information that you do
not wish to make public. Proprietary, classified, confidential, or
sensitive information should not be included in your comments.
Please note that any written comments NIH receives may be posted
[[Page 37521]]
unredacted to the Office of Science Policy website.
Information is also available on the NIH Office of Science
Policy website: https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings, where an agenda, link to the webcast meeting, and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: June 17, 2022.
Victoria Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-13419 Filed 6-22-22; 8:45 am]
BILLING CODE 4140-01-P